Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
21.87
+0.09 (0.41%)
Sep 23, 2026, 3:04 PM CST
SHE:002880 Market Cap
SHE:002880 has a market cap or net worth of 4.96 billion as of September 23, 2026. Its market cap has decreased by -18.46% in one year.
Market Cap
4.96B
Enterprise Value
5.74B
Revenue
1.20B
Ranking
n/a
PE Ratio
27.09
Stock Price
21.87
ChartMarket Cap Chart
Since June 16, 2017, SHE:002880's market cap has increased from 3.91B to 4.96B, an increase of 27.01%. That is a compound annual growth rate of 2.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.96B | -14.24% |
| Dec 31, 2025 | 5.78B | -5.59% |
| Dec 31, 2024 | 6.13B | -23.11% |
| Dec 29, 2023 | 7.97B | 10.16% |
| Dec 30, 2022 | 7.23B | -0.90% |
| Dec 31, 2021 | 7.30B | -6.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shouyao Holdings (Beijing) Co., LTD. | 5.87B |
| Boji Medical Technology | 5.81B |
| Wuhan Keqian Biology Co.,Ltd | 5.73B |
| Shanghai Obio Technology (Group) Corp. | 5.47B |
| ChemPartner PharmaTech | 5.05B |
| Kexing Biopharm | 5.00B |
| Beijing Konruns Pharmaceutical | 4.70B |
| Anhui Huaheng Biotechnology | 4.56B |